August 01, 2011
Fera Pharmaceuticals announced that it has launched four ophthalmic ointments: Neo-Polycin (neomycin and polymyxin B sulfates and bacitracin zinc), Neo-Polycin HC (neomycin and polymyxin B sulfates, bacitracin zinc and hydrocortisone acetate), Polycin (bacitracin zinc and polymyxin B sulfates), and neomycin and polymyxin B sulfates with dexamethasone.
April 28, 2011
OCuSOFT has made available the Ocudox Convenience Kit for the treatment of acute eyelid disease.
November 10, 2010
Alcon announced that TobraDex ST (tobramycin and dexamethasone ophthalmic suspension) has been made available for the treatment of steroid-responsive inflammatory ocular conditions where superficial bacterial ocular infection or risk of infection exists.
October 18, 2010
Fera announced that it has launched a preservative-free formulation of Garamycin (gentamicin sulfate ophthalmic ointment).
May 20, 2010
The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.